HK1045324A1 - 病毒變體 - Google Patents

病毒變體

Info

Publication number
HK1045324A1
HK1045324A1 HK02105108.6A HK02105108A HK1045324A1 HK 1045324 A1 HK1045324 A1 HK 1045324A1 HK 02105108 A HK02105108 A HK 02105108A HK 1045324 A1 HK1045324 A1 HK 1045324A1
Authority
HK
Hong Kong
Prior art keywords
viral variants
viral
variants
Prior art date
Application number
HK02105108.6A
Other languages
English (en)
Inventor
Bartholomeusz Angeline
Littlejohn Margaret
Ayres Anna
Locarnini Stephen
Original Assignee
Melbourne Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melbourne Health filed Critical Melbourne Health
Publication of HK1045324A1 publication Critical patent/HK1045324A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02105108.6A 1999-04-09 2002-07-09 病毒變體 HK1045324A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9679A AUPP967999A0 (en) 1999-04-09 1999-04-09 Viral variants
PCT/AU2000/000294 WO2000061758A1 (en) 1999-04-09 2000-04-07 Viral variants

Publications (1)

Publication Number Publication Date
HK1045324A1 true HK1045324A1 (zh) 2002-11-22

Family

ID=3813877

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105108.6A HK1045324A1 (zh) 1999-04-09 2002-07-09 病毒變體

Country Status (7)

Country Link
US (2) US7291453B1 (zh)
EP (3) EP2360257A3 (zh)
CN (1) CN1351663A (zh)
AU (2) AUPP967999A0 (zh)
ES (1) ES2545527T3 (zh)
HK (1) HK1045324A1 (zh)
WO (1) WO2000061758A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40233E1 (en) 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
US7405039B2 (en) 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
TR200402517T1 (tr) 2002-03-29 2007-12-24 Innogenetics N.V. HBV ilaç direnci tespit metotları
WO2003087351A1 (en) 2002-04-12 2003-10-23 Melbourne Health Hepatitis b viral variants with redused susceptibility to nucleoside analogs and uses thereof
EP2404933A3 (en) * 2003-10-21 2012-04-25 Melbourne Health HBV variants detection and application
EP1858916B1 (en) 2005-03-15 2014-07-09 Fujirebio Europe N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
PT1858915E (pt) 2005-03-15 2014-06-11 Justus Liebig Universität Giessen Variantes do vírus de hepatite b resistentes contra alguns análogos de nucleósido, mas sensíveis a outros, e suas utilizações
WO2006105597A1 (en) 2005-04-08 2006-10-12 Melbourne Health Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
AU2006230802A1 (en) 2005-04-08 2006-10-12 Austin Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
US20080124760A1 (en) * 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
CN101517076B (zh) * 2006-08-18 2012-12-12 雀巢产品技术援助有限公司 双歧杆菌中的遗传重建
WO2009139515A1 (en) * 2008-05-16 2009-11-19 Pusan National University Industry-University Cooperation Foundation Method for detection of multi-drug resistant hepatitis b virus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
AU681636B2 (en) * 1993-03-24 1997-09-04 Imperial College Of Science, Technology And Medicine Hepatitis B escape mutant specific binding molecules
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AU734831C (en) * 1996-11-08 2002-05-09 Melbourne Health Viral variants and methods for detecting same
US7038035B1 (en) * 1998-06-19 2006-05-02 Government Of Republic Of Singapore Vaccine-induced hepatitis B viral strain and uses thereof
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants

Also Published As

Publication number Publication date
EP1169452A4 (en) 2005-05-11
AUPP967999A0 (en) 1999-05-06
WO2000061758A1 (en) 2000-10-19
AU3648000A (en) 2000-11-14
EP1609865A3 (en) 2008-06-11
EP2360257A3 (en) 2013-08-28
US7291453B1 (en) 2007-11-06
US20080171313A1 (en) 2008-07-17
EP1609865A2 (en) 2005-12-28
AU779489B2 (en) 2005-01-27
ES2545527T3 (es) 2015-09-11
EP1169452A1 (en) 2002-01-09
EP2360257A2 (en) 2011-08-24
EP1609865B1 (en) 2015-05-27
CN1351663A (zh) 2002-05-29
US8273527B2 (en) 2012-09-25

Similar Documents

Publication Publication Date Title
DE60008112D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE60008382D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE50008011D1 (en) Thixotropierungsmittel
DE60018288D1 (en) Polyphenylensulfidlegierungszusammensetzung
DE60007505D1 (en) Propargyletherderivate
HK1045324A1 (zh) 病毒變體
DE60011809D1 (en) Oxcarbazepinsuspension
DE50000137D1 (en) Spirofluorenopyrane
DE59909975D1 (en) Testleck
DE60001313D1 (en) Imidazodiazepinderivate
DE10081629D2 (en) Seilzugbefestigung
DE50009469D1 (en) Common-rail-injektor
DE60012950D1 (en) Polyacetalharzzusammensetzung
DE50010757D1 (en) Stilbenaufheller
DE50008218D1 (en) Common-rail-injektor
DE50012999D1 (en) Stirnwandisolation
DE60004080D1 (en) Centroidintegration
DE60012212D1 (en) Orthotopisches totalkunstherz
GB9913742D0 (en) Horologe improvement
AU141428S (en) Turnpiece
DE50012739D1 (en) Thermovliesstoff
DE50008219D1 (en) Common-rail-injektor
DE60007846D1 (en) Sterndreieckschalter
DE60014693D1 (en) O-desmethylvenlafaxin-ether